- Home
- ESPR vs TSVT Comparison
ESPR vs TSVT Comparison
Compare ESPR & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- TSVT
- Stock Information
- Founded
- ESPR 2008
- TSVT 2021
- Country
- ESPR United States
- TSVT United States
- Employees
- ESPR N/A
- TSVT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ESPR Health Care
- TSVT Health Care
- Exchange
- ESPR Nasdaq
- TSVT Nasdaq
- Market Cap
- ESPR 305.0M
- TSVT 258.9M
- IPO Year
- ESPR 2013
- TSVT N/A
- Fundamental
- Price
- ESPR $0.95
- TSVT $4.98
- Analyst Decision
- ESPR Buy
- TSVT Buy
- Analyst Count
- ESPR 7
- TSVT 4
- Target Price
- ESPR $6.07
- TSVT $6.50
- AVG Volume (30 Days)
- ESPR 5.5M
- TSVT 1.1M
- Earning Date
- ESPR 05-06-2025
- TSVT 05-07-2025
- Dividend Yield
- ESPR N/A
- TSVT N/A
- EPS Growth
- ESPR N/A
- TSVT N/A
- EPS
- ESPR N/A
- TSVT N/A
- Revenue
- ESPR $332,314,000.00
- TSVT $37,862,000.00
- Revenue This Year
- ESPR $5.17
- TSVT $84.48
- Revenue Next Year
- ESPR N/A
- TSVT $9.69
- P/E Ratio
- ESPR N/A
- TSVT N/A
- Revenue Growth
- ESPR 185.66
- TSVT N/A
- 52 Week Low
- ESPR $0.93
- TSVT $2.29
- 52 Week High
- ESPR $3.94
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- ESPR 22.73
- TSVT 76.79
- Support Level
- ESPR $0.93
- TSVT $4.88
- Resistance Level
- ESPR $1.06
- TSVT $4.99
- Average True Range (ATR)
- ESPR 0.09
- TSVT 0.03
- MACD
- ESPR -0.02
- TSVT -0.08
- Stochastic Oscillator
- ESPR 3.57
- TSVT 90.91
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.